Global Embolic Protection Devices Market

Report ID : 1454 | Published : 2022-11-22 | Pages: | Format: PDF/EXCEL

The market size of the Global Embolic Protection Devices Market in the year 2021 is valued at 1068.29 million and is predicted to reach 2177.36 million by the year 2030 at an 8.41% CAGR during the forecast period.

Stenting reduces distal embolization because embolic protection devices (EPDs) catch blood and luminal particles inside the SVG. It offers the most dependable evidence-based strategy for stopping major adverse cardiovascular events (MACE) and periprocedural MI during SVG operations. This tool is intended to capture and remove any debris that might be released during processes. By preventing or decreasing plaque particles from entering the distal bed, embolic protection devices (EPDs) can potentially improve clinical outcomes. The market for embolic protection devices will grow more quickly due to the increased demand for minimally invasive procedures. Embolic protection devices (EPD) during percutaneous cardiac surgeries have reduced the issues brought on by debris entering the bloodstream and obstructing smaller capillaries. This will boost the market's growth rate by increasing demand for embolic protection devices.

The increase in the population of older people is a crucial factor contributing to the market's growth. Additionally, rising healthcare costs and technological innovation are the main factors that will accelerate market expansion. The prevalence of cardiovascular and neurovascular illnesses is also expected to benefit the market's growth rate. On the other hand, substantial R&D expenditures and a rise in product failure and recall rates will restrain market expansion. Additionally, a rigorous regulatory environment and unfavourable government regulations will pose a hurdle to the market for embolic protection devices.

Market Segmentation:

The embolic protection devices market is segmented on the product, application, material and end-use. Based on the product, the market is segmented into distal occlusion systems, distal filters and proximal occlusion systems. Based on application, the embolic protection devices market is segmented into neurovascular disease, cardiovascular disease and peripheral disease. Based on the material, the embolic protection devices market is segmented into nitinol and polyurethane. Based on the end-user, the embolic protection devices market is segmented into ambulatory surgical centres, hospitals and others.

Based on product, the distal filters segment is accounted as a significant contributor to the embolic protection devices market.

Based on the product, the market is segmented into distal occlusion systems, distal filters and proximal occlusion systems. The distal filters category grabbed the highest revenue share, and it is anticipated that they will continue to hold that position during the anticipated time attributed to the procedural advantages distal filter devices provide, including user comfort, enhanced visibility, and the device's crossing profile. In addition to the device's benefits, the global rise in the prevalence of cardiovascular and neurovascular disorders has further encouraged the segment's growth. According to the American Heart Association, almost 801,000 deaths in the United States are attributed to cardiovascular disease (CVD), accounting for around one in three fatalities in the nation. About 2,200 Americans every day, or one every 40 seconds, pass away from cardiovascular disease. According to statistics, the growing patient base leads to an increase in angioplasty operations and surgeries that call for an embolic prevention device, which drives the segment's expansion.

The cardiovascular disease segment witnessed growth at a rapid rate.

Based on application, the embolic protection devices market is segmented into neurovascular disease, cardiovascular disease and peripheral disease. The cardiovascular disease category is anticipated to grow significantly over the forecast period. Cardiovascular operations primarily involve embolic protection devices, then peripheral vascular diseases (PVDs). The prevalence of cardiovascular diseases (CVDs) is predicted to increase in line with the growing elderly population, which will be advantageous for the industry. A blood ailment called PVD causes arteries and veins outside the brain and heart to narrow due to plaque accumulation following surgery. According to the Centers for Disease Control and Prevention (CDC), PVD affects 12 to 20% of Americans who are 60 years or older in the United States. Because of the growing prevalence of lifestyle problems and increased knowledge of minimally invasive techniques, it is projected that the peripheral diseases market will have significant growth.

The North American embolic protection devices market holds a significant regional revenue share.

The North American embolic protection devices market is expected to register the highest market share in revenue shortly. Transcatheter aortic valve replacement (TAVR) procedures are becoming more popular in the area, and the number of patients with chronic illnesses is rising. These trends will influence the industry's future. The rise in obesity instances brought on by lifestyle modifications, unhealthy eating habits, and the large concentration of leading industry players in the region are additional factors that will favourably affect North American market statistics. Additionally, the Asia Pacific is anticipated to expand at a significant rate over the course of the forecast period. The market for embolic protection devices will grow more quickly due to end users being encouraged to use new products and technologically advanced methods. Additional factors fueling the market's growth include rising R&D expenditures, technologically advanced infrastructure in the region, and rising healthcare costs.

Competitive Landscape

Some major key players in the embolic protection devices market are Abbott Laboratories, Allium Medica, Boston Scientific Corporation, Cardinal Health, Contego Medical, LLC, Edwards Lifesciences Corporation, W. L. Gore & Associates (Gore Medical), Innovative Cardiovascular Solutions, LLC, Keystone Heart, Medtronic, Metactive Medical, and Transverse Medical, Inc.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Embolic Protection Devices Market Snapshot

Chapter 4. Global Embolic Protection Devices Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Product Estimates & Trend Analysis

5.1. by Product & Market Share, 2019 & 2030

5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Product:

5.2.1. Distal Occlusion Systems

5.2.2. Distal Filters

5.2.3. Proximal Occlusion Systems

Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis

6.1. by Application & Market Share, 2019 & 2030

6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Application:

6.2.1. Neurovascular Disease

6.2.2. Cardiovascular Disease

6.2.3. Peripheral Disease

Chapter 7. Market Segmentation 3: by Material Estimates & Trend Analysis

7.1. by Material & Market Share, 2019 & 2030

7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Material:

7.2.1. Nitinol

7.2.2. Polyurethane

Chapter 8. Market Segmentation 4: by End-Use Estimates & Trend Analysis

8.1. by End-Use & Market Share, 2019 & 2030

8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by End-Use:

8.2.1. Ambulatory Surgical Centers

8.2.2. Hospitals

8.2.3. Others

Chapter 9. Embolic Protection Devices Market Segmentation 5: Regional Estimates & Trend Analysis

9.1. North America

9.1.1. North America Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by Product, 2022-2030

9.1.2. North America Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2030

9.1.3. North America Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by Material, 2022-2030

9.1.4. North America Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2022-2030

9.1.5. North America Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

9.2. Europe

9.2.1. Europe Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by Product, 2022-2030

9.2.2. Europe Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2030

9.2.3. Europe Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by Material, 2022-2030

9.2.4. Europe Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2022-2030

9.2.5. Europe Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

9.3. Asia Pacific

9.3.1. Asia Pacific Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by Product, 2022-2030

9.3.2. Asia Pacific Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2030

9.3.3. Asia-Pacific Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by Material, 2022-2030

9.3.4. Asia-Pacific Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2022-2030

9.3.5. Asia Pacific Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

9.4. Latin America

9.4.1. Latin America Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by Product, 2022-2030

9.4.2. Latin America Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2030

9.4.3. Latin America Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by Material, 2022-2030

9.4.4. Latin America Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2022-2030

9.4.5. Latin America Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

9.5. Middle East & Africa

9.5.1. Middle East & Africa Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by Product, 2022-2030

9.5.2. Middle East & Africa Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2030

9.5.3. Middle East & Africa Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by Material, 2022-2030

9.5.4. Middle East & Africa Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2022-2030

9.5.5. Middle East & Africa Embolic Protection Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

Chapter 10. Competitive Landscape

10.1. Major Mergers and Acquisitions/Strategic Alliances

10.2. Company Profiles

10.2.1. Abbott Laboratories

10.2.2. Allium Medica

10.2.3. Boston Scientific Corporation

10.2.4. Cardinal Health

10.2.5. Contego Medical, LLC

10.2.6. Edwards Lifesciences Corporation

10.2.7. W. L. Gore & Associates (Gore Medical)

10.2.8. Innovative Cardiovascular Solutions, LLC

10.2.9. Keystone Heart

10.2.10. Medtronic

10.2.11. Metactive Medical

10.2.12. Transverse Medical, Inc.

10.2.13. Other Prominent Players

By Product-

  • Distal Occlusion Systems
  • Distal Filters
  • Proximal Occlusion Systems

By Application-

  • Neurovascular Disease
  • Cardiovascular Disease
  • Peripheral Disease

By Material-

  • Nitinol
  • Polyurethane

By End-Use-

  • Ambulatory Surgical Centers
  • Hospitals
  • Others

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients